Urolithin A Dosage: How Much Should You Take?

Most clinical trials testing Urolithin A in humans have used daily doses of 500 mg or 1,000 mg, and both amounts have produced measurable improvements in muscle strength and endurance over periods of two to four months. No regulatory body has set an official recommended daily dose because Urolithin A is sold as a supplement, not a pharmaceutical. But the converging evidence from randomized, placebo-controlled trials gives a reasonably clear picture of the range that works and the range that appears safe, even if some of the finer details are still being sorted out.

What the Clinical Trials Actually Used

The largest and most frequently cited human trial randomized middle-aged adults to receive either 500 mg, 1,000 mg, or a placebo daily for four months. Both supplement groups showed statistically significant gains in leg muscle strength compared to placebo. Hamstring peak torque rose by about 12 percent in the 500 mg group and roughly 10 percent in the 1,000 mg group. Maximum torque during knee flexion improved by about 10.5 percent in both groups. The 1,000 mg dose also produced a significant within-group increase in peak oxygen uptake at both the two-month and four-month marks, something the lower dose did not clearly achieve.¹

A separate randomized trial in older adults, published in JAMA Network Open, tested 1,000 mg daily over four months and found significant improvements in muscle endurance, measured as the number of contractions a muscle could perform before fatigue. The gains showed up as early as two months into supplementation.² Together, these two trials form the backbone of current dosage recommendations in the supplement industry. The practical takeaway is that 500 mg is enough to see meaningful strength changes, while 1,000 mg may offer additional aerobic-fitness benefits on top of the strength gains.

Does Doubling the Dose Double the Benefit?

Not exactly. The relationship between dose and outcome is not as straightforward as “more is better.” In the four-month strength trial, the 500 mg group actually had a slightly larger increase in hamstring peak torque than the 1,000 mg group. Where the higher dose pulled ahead was in aerobic capacity measures. This is a common pattern in supplement research: once a threshold is met, additional compound may only help in specific dimensions rather than amplifying every effect proportionally.

A recent pooled analysis of muscle-health trials tried to quantify walking-distance improvements by combining the 500 mg and 1,000 mg arms against placebo. The pooled improvement was roughly 17 meters on the six-minute walk test, but the result did not reach statistical significance.³ That does not mean the supplement is useless for walking capacity. It means the trials so far are relatively small, and pooling them still does not give enough statistical power to rule out chance. Strength and endurance outcomes, which were measured differently, did reach significance. If your primary goal is leg strength, the evidence at 500 mg is solid. If you are also interested in aerobic performance, 1,000 mg has more supporting data, though the evidence is still early-stage.

Pharmacokinetic data show that blood levels of Urolithin A rise in a dose-dependent manner over a 28-day supplementation period, so the body is clearly absorbing more at higher doses.⁴ Whether that extra circulating compound translates into proportionally better outcomes at every dose level remains an open question.

Why Food Sources Are Unreliable for Most People

Urolithin A does not exist in food. Your body makes it, or rather, certain bacteria in your gut make it from compounds called ellagitannins found in pomegranates, walnuts, and some berries. The problem is that not everyone’s gut microbiome can do this. Research using fecal samples from healthy volunteers found that only about half of them could metabolize the precursor compound into Urolithin A at all. The enzyme responsible, encoded by a gene cluster called the ucd operon, was entirely absent in the gut communities of non-producers.⁵

Even among people who can produce Urolithin A from food, there is wide variation. Metagenomic analysis of people who drank pomegranate juice classified them into non-producers, low producers, and high producers. The ability to convert dietary precursors into Urolithin A was significantly tied to gut microbiome diversity: producers had richer, more varied microbial communities than non-producers.⁶ That same study found that direct supplementation with Urolithin A bypassed this bottleneck entirely, producing consistent plasma levels regardless of a person’s microbiome profile. In other words, even if you eat pomegranates by the bushel, you have no way of knowing whether your gut is converting enough of the precursors to match what a supplement delivers. Direct supplementation removes the guesswork.

How Safe Are These Doses?

The safety data so far are reassuring, at least within the dose range that has been tested. A first-in-human clinical trial specifically designed to evaluate safety found that Urolithin A had a favorable safety profile, with no concerning side effects after single oral doses up to 2,000 mg or after daily dosing of up to 1,000 mg for 28 days in healthy older adults aged 61 to 85.⁷⁸ That 2,000 mg figure is worth keeping in mind: it is double the highest dose used in the longer efficacy trials and was still well tolerated in the short term.

From a regulatory standpoint, the U.S. FDA has issued a “no questions” response to GRAS Notice No. 791 for specified food uses of Urolithin A. That means the FDA reviewed the manufacturer’s safety evidence and did not object to the conclusion that it is generally recognized as safe for those uses.⁹ This is not a ringing endorsement of therapeutic doses, and it tells you nothing about long-term safety at 1,000 mg per day over years. But it does clear a basic regulatory hurdle that many popular supplements never bother to pursue.

No serious adverse events have been reported in any published human trial to date. The most common side effects in the longer trials were mild gastrointestinal complaints, which occurred at similar rates in the supplement and placebo groups. If you are taking medications that are heavily metabolized by the liver, it is worth mentioning the supplement to your doctor, but there are no documented drug interactions in the literature as of mid-2025.

What About Athletes and Younger Adults?

Most early Urolithin A research focused on older adults, where age-related mitochondrial decline makes the potential benefit most obvious. But recent trials have started testing it in younger, physically active populations, and the results are interesting.

A pilot trial in academy soccer players during preseason gave participants 500 mg of Urolithin A daily. The supplement group showed a significantly greater improvement in the Yo-Yo intermittent recovery test, a standard measure of repeated high-intensity running capacity, gaining an estimated 239 meters more than the placebo group. Countermovement jump height also improved by about 3.3 centimeters relative to placebo.¹⁰ These are meaningful gains in a population that is already fit and training hard, where marginal improvements are harder to achieve.

An eight-week study in male athletes with resistance training experience tested Urolithin A supplementation (also at 500 mg) and found significant improvements in maximum voluntary isometric contraction and repetitions to failure compared to placebo.¹¹ The fact that benefits show up in trained athletes, not just sedentary older adults, suggests that the mechanism at work is not simply compensating for an age-related deficit. It appears to be enhancing mitochondrial function in a way that helps even people whose mitochondria are already reasonably healthy.

For athletes considering supplementation, 500 mg daily appears to be the dose with the most direct supporting evidence. None of the athletic performance trials used 1,000 mg, so there is currently no data suggesting the higher dose works better in this population.

The Supplement Quality Problem

Here is where things get uncomfortable. A study that tested commercially available Urolithin A supplements found dramatic deviations from what was claimed on the label, ranging from about 29 percent more than labeled all the way down to zero detectable active ingredient.¹² A product claiming 500 mg per capsule might contain 640 mg or it might contain nothing at all. This is not unique to Urolithin A; it is a widespread problem in the supplement industry, where manufacturers are not required to prove potency before selling a product.

The practical consequence is that your carefully chosen dose of 500 mg or 1,000 mg is only as meaningful as the quality of the specific product you buy. Third-party testing certifications (NSF, USP, or Informed Sport) can help, though not many Urolithin A brands carry them yet. The branded ingredient Mitopure, manufactured by the company that funded most of the clinical trials, is the form that has been used in the published research. That does not automatically make it the best product on the market, but it does mean the dose stated on the label matches what was tested in the trials. If you opt for a generic alternative, the evidence supporting your dose becomes less certain because the actual compound in the capsule is less certain.

How Urolithin A Works at the Cellular Level

The compound’s primary mechanism is promoting mitophagy, the process by which cells identify and recycle damaged mitochondria. As mitochondria age or accumulate damage, they become less efficient at producing energy and can generate harmful byproducts. Mitophagy clears these underperformers so the cell can replace them with fresh ones. Research has identified that Urolithin A activates this cleanup process by upregulating a protein called Parkin, which tags damaged mitochondria for removal.¹³

This is relevant to dosage because the mitophagy benefit appears to accumulate over time rather than kicking in after a single dose. The clinical trials showing functional improvements ran for two to four months, and the aerobic capacity gains in the four-month trial only became statistically significant by month two. If you are expecting immediate results, you will be disappointed. The compound’s mechanism suggests that consistent daily supplementation over at least eight weeks is necessary to see meaningful changes, which aligns with what the trials have shown.

Beyond Muscles and Aging

While the dosage discussion centers on muscle health because that is where the human trial data lives, Urolithin A is being investigated for a range of other effects, mostly in animal models and cell studies so far.

In lab experiments using immune cells, Urolithin A at concentrations of 25 to 50 micromolar significantly suppressed several inflammatory markers, including IL-6, TNF-alpha, and IL-1 beta, bringing them close to the levels seen in unstimulated cells.¹⁴ These are cell-culture findings, and the leap from a petri dish to a clinical recommendation is enormous. But they point toward a plausible anti-inflammatory pathway that could explain some of the benefits seen in the human trials beyond pure mitochondrial effects.

Animal studies of obesity have shown that Urolithin A improved insulin sensitivity and reduced liver triglyceride accumulation in mice fed high-fat diets. It also shifted immune-cell behavior in fat tissue toward a less inflammatory profile.¹⁵ Results on body weight were inconsistent across studies, with some showing reductions and others showing none, possibly because different doses and delivery methods were used.⁸ None of these metabolic findings have been confirmed in human trials at specific doses, so they should not drive your dosage decisions. They do suggest, however, that the compound is doing more in the body than just recycling worn-out mitochondria in muscle cells.

Timing, Food, and Practical Considerations

The published trials generally administered Urolithin A in the morning with breakfast, and pharmacokinetic data confirm that the compound is absorbed and appears in the bloodstream within a few hours. There is no published evidence that taking it at a different time of day reduces effectiveness, but consistency matters more than timing. Pick a time you will remember and stick with it.

Whether to take it with food is a more practical question. Urolithin A is a lipophilic compound, meaning it dissolves more readily in fat than in water. Most capsule formulations include a lipid carrier for this reason. Taking it alongside a meal that contains some fat is a reasonable precaution, though no trial has directly compared fed versus fasted absorption at the supplement doses humans actually take.

If you are new to supplementation and want to start conservatively, 500 mg daily is the dose with the broadest evidence across multiple populations, from older sedentary adults to young athletes. If you are specifically interested in aerobic fitness improvements or are dealing with age-related muscle decline, the 1,000 mg dose has additional supporting data, particularly for peak oxygen uptake. Going above 1,000 mg daily has no clinical trial support for added benefit, and while single doses up to 2,000 mg have been tolerated, long-term safety at that level has not been studied.

One thing worth managing expectations about: Urolithin A is not a performance-enhancing drug in the traditional sense. The strength improvements seen in trials, roughly 10 to 12 percent in hamstring torque, are real and statistically significant but modest. They are closer to what you might gain from a few weeks of consistent resistance training than to anything dramatic. The compound seems to work best as part of an overall strategy that includes exercise, not as a replacement for it. In fact, its mechanism of clearing damaged mitochondria and stimulating new ones is essentially doing at a cellular level what exercise also does, which may explain why the two appear to complement each other.